We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

このDR 2018について

Aravind眼科病院、マドゥライ:月6-7、2018 - 糖尿病性網膜症シンポジウム

Symposium on Diabetic Retinopathy - Jan 6-7, 2018 :Aravind Eye Hospital, Madurai

Aravind Eye Hospital is honoured to welcome you to its popular biennial 7th Symposium on Diabetic Retinopathy. This year it is being cohosted by the other 3 major eye institutes of South India - Sankara Nethralaya, LVPEI and Narayana Nethralaya.

In today's world, there are several exciting developments taking place rapidly in the management of diabetic retinopathy. There is a Paradigm shift in the management of retinopathy from Lasers to a whole gamut of Pharmacotherapy. You will be hearing directly from the very people doing the cutting edge research. The eminent faculty members from leading research centres in USA, UK & Singapore will share their views on current developments and future trends in this field. This meeting will focus onlyon diabetic retinopathy discussing from the basic of DR to the treatments that are out in the horizon.

With the advent of Pharmacotherapy, even the general ophthalmologists are treating DR and so it becomes all the more important for every ophthalmologist to learn all aspects of DR management.

We invite you to join us, in this prestigious symposium that promises to be stimulating and rewarding for all participants.

Dr. R. Kim

Organising Secretary - DR 2018

Chief - Retina Vitreous Services

Chief Medical Officer

Aravind Eye Hospital, Madurai

最新バージョン 1.0.1 の更新情報

Last updated on 2023年01月19日

Sessions
Discussion
Faculty
Going to Madurai
Sightseeing
Contact us

翻訳中...

アプリの追加情報

最終のバージョン

DR 2018 更新を申請する 1.0.1

投稿者

Esa

Android 要件

Android 2.1+

Available on

DR 2018 をPlayストアでダウンロード

もっと見る

DR 2018 スクリーンショット

APKPureをを購読する
最高のAndroidゲームアプリの最新リリースやニュースやガイドなどの情報にいち早くアクセスすることができます。
いいえ結構です
購読
購読完了!
APKPureの購読が完了しました。
APKPureをを購読する
最高のAndroidゲームアプリの最新リリースやニュースやガイドなどの情報にいち早くアクセスすることができます。
いいえ結構です
購読
成功!
ニュースレターを購読しました。